Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript

HRMY earnings call for the period ending March 31, 2024.

Related Keywords

California , United States , San Francisco , Raymond James , Graig Suvannavejh , Piper Sandler , Jeff Dayno , David Amsellem Piper Sandler , Sandip Kapadia , Corinne Jenkins , Jason Gerberry , Brisebois Oppenheimer , Graig Suvannavejh Mizuho , Luis Sanay , Kumar Budur , Charles Duncan Cantor Fitzgerald , Jeff Dierks , Charles Duncan , Corinne Jenkins Goldman Sachs , Fadia Needham , Francois Brisebois , Danielle Brill , Danielle Brill Raymond James , David Amsellem , Teijin Pharma , Scott Baraban , America Merrill Lynch , Alkermes , Goldman Sachs , Cantor Fitzgerald , University Of California , Jason Gerberry Bank , Company Analyst , Harmony Biosciences , Harmony Bioscience , Chief Executive , Epygenix Therapeutics , Prader Willi Syndrome , Dravet Syndrome , Rare Pediatric Disease Designation , Ami Fadia , Novel Chemical Scaffolds , Novel Chemical Scaffold ,